Vor Biopharma Inc. (VOR) SEC Filings — 2024
18 SEC filings for Vor Biopharma Inc. (VOR) in 2024.
Filings
- Vor Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 27, 2024
- Vor Biopharma Inc. 8-K Filing — 8-K · Dec 9, 2024
- Vor Biopharma Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Vor Biopharma Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Vor Biopharma Files 8-K: Officer/Director Changes & Financials — 8-K · Sep 30, 2024
- Vor Biopharma Files 8-K with Updates — 8-K · Sep 5, 2024
- Vor Biopharma to be Delisted from Nasdaq — 8-K · Aug 30, 2024
- Vor Biopharma Files Q1 2024 10-Q Amendment — 10-Q/A · Aug 8, 2024
- Vor Biopharma Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Vor Biopharma Announces Board and Executive Changes — 8-K · Jun 10, 2024
- Vor Biopharma Files 8-K on Officer/Director Changes & Votes — 8-K · May 28, 2024
- Vor Biopharma Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Vor Biopharma Appoints New CMO & CSO — 8-K · May 2, 2024
- Vor Biopharma Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 9, 2024
- Vor Biopharma Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 20, 2024
- 5AM Ventures Amends Vor Biopharma Stake Disclosure — SC 13D/A · Feb 14, 2024
- FMR LLC & Abigail Johnson Maintain 11.24% Stake in Vor Biopharma — SC 13G/A · Feb 9, 2024
- Vor Biopharma Files 8-K for 'Other Events' on Jan 5, 2024 — 8-K · Jan 5, 2024